Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001564357 | SCV001787513 | likely benign | not provided | 2020-05-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002440802 | SCV002749002 | uncertain significance | Cardiovascular phenotype | 2021-06-03 | criteria provided, single submitter | clinical testing | The p.N918S variant (also known as c.2753A>G), located in coding exon 42 of the COL1A2 gene, results from an A to G substitution at nucleotide position 2753. The asparagine at codon 918 is replaced by serine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species, and serine is the reference amino acid in other vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |